More Post from the Author
- Kaiju No. 8 is Here to Celebrate 100,000 Pre-Registration Sign Ups!
- IMA Medical Group refuerza su compromiso durante la transformacin del sector de la salud
- Social Studies Experts Expand to Alabama: Gallopade Introduces Newest State Curriculum
- Education Leaders Convene at U.S. News Summit Navigating Higher Education's Future
- Spin Master Reports Q1 2025 Financial Results
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC

Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Kaiju No. 8 is Here to Celebrate 100,000 Pre-Registration Sign Ups!
- IMA Medical Group refuerza su compromiso durante la transformacin del sector de la salud
- Social Studies Experts Expand to Alabama: Gallopade Introduces Newest State Curriculum
- Education Leaders Convene at U.S. News Summit Navigating Higher Education's Future
- Spin Master Reports Q1 2025 Financial Results